|
Reference #:
2005-172
Inventors/Contributors
Yuan-Ping Pang, Ph.D., Jewn Giew Park, Ph.D., Jing Tang, Ph.D.
Description
Serotype selective and nonpeptidic inhibitors of botulinum neurotoxin serotype A (BoNTA) have been developed. These inhibitors are effective in detoxifying botulinum neurotoxin serotype A; they can be used as therapeutics for treating food poisoning by BoNTA, overdose of BoNTA-based cosmetics such as Botox, and they can also be used as countermeausres to BoNTA-based biological weapons.
Patent Status
Pending |
|
Contact
Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 538-1652
Fax: (507) 284-5410
|
|
|
